HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
B K Link Selected Research
B K Link Research Topics
Disease
3
Lymphoma (Lymphomas)
01/2017 - 01/2001
3
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2017 - 12/2001
3
Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2005 - 09/2000
2
Breast Neoplasms (Breast Cancer)
09/2001 - 02/2001
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2018
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2017
1
Hodgkin Disease (Hodgkin's Disease)
10/2008
1
Disease Progression
11/2005
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2005
1
Chromosome Aberrations (Chromosome Abnormalities)
05/2005
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2004
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2001
1
Fever (Fevers)
01/2001
1
Chills
01/2001
1
Neoplasms (Cancer)
01/2001
1
Hyperplasia
01/2001
Drug/Important Bio-Agent (IBA)
3
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2005 - 01/2001
3
Rituximab (Mabthera)
FDA Link
11/2005 - 09/2000
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2005 - 01/2001
2
Vitamin D
FDA Link
Generic
01/2017 - 01/2017
2
Vincristine (Oncovin)
FDA Link
Generic
11/2005 - 01/2001
2
Prednisone (Sone)
FDA Link
Generic
11/2005 - 01/2001
2
Monoclonal Antibodies
IBA
12/2001 - 09/2000
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2018
1
hydroxide ion
IBA
01/2017
1
B7-H1 Antigen
IBA
01/2017
1
Biomarkers (Surrogate Marker)
IBA
01/2017
1
Biological Products
IBA
05/2005
1
apolizumab
IBA
12/2001
1
Paclitaxel (Taxol)
FDA Link
Generic
02/2001
1
CpG ODN 2006
IBA
01/2001
1
Oligodeoxyribonucleotides
IBA
01/2001
1
CPG-oligonucleotide
IBA
01/2001
1
Antigens
IBA
01/2001
Therapy/Procedure
5
Therapeutics
10/2008 - 09/2000
2
Drug Therapy (Chemotherapy)
11/2005 - 01/2001
2
Adjuvant Chemotherapy
09/2001 - 02/2001
1
Liver Transplantation
11/2004
1
Organ Transplantation
11/2004
1
Immunotherapy
01/2001